CUREvsIBRN
DIREXION DAILY HEALTHCARE BULL 3X SHARES against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| CURE | IBRN | |
|---|---|---|
| Expense ratio | — | 0.47% |
| Assets | $203M | $7864.21T |
| Net flow, 1 month | −$13M | +$2M |
| Net flow, 1 year | −$80M | +$2M |
| Return, YTD | +28.1% | +24.7% |
| Return, 1 year | +76.0% | +57.5% |
| Avg daily volume | 70K | 3K |
| Holdings | 65 | 54 |
| Listed | May 1, 2024 | Aug 23, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS